$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics
10:35am, Tuesday, 29'th Apr 2025
Although the revenue and EPS for Novartis (NVS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street
Novartis Beats on Q1 Earnings and Sales, Raises Guidance, Stock Up
10:31am, Tuesday, 29'th Apr 2025
NVS' first-quarter earnings and sales beat estimates. Based on the strong momentum of its key drugs, the company raises its annual guidance.
Novartis posts better-than-expected first-quarter sales, raises full-year guidance
04:22am, Tuesday, 29'th Apr 2025
Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance. Net sales were up 15% on a constant currency basis to $13.2 billion
Novartis Lifts Guidance After Profit, Sales Top Views
01:27am, Tuesday, 29'th Apr 2025
Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs.
Novartis more upbeat on 2025 guidance after strong Q1 momentum
01:12am, Tuesday, 29'th Apr 2025
Novartis on Tuesday issued a more optimistic full-year earnings guidance, citing strong growth of drugs such as Kisqali, Kesimpta and Leqvio during the first quarter.
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
07:28am, Monday, 28'th Apr 2025
Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manuf
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
10:15am, Saturday, 26'th Apr 2025
President Donald Trump's macroeconomic policies are taking center stage on Wall Street. The 47th U.S. president has decided to implement aggressive tariffs on imported goods from most countries, altho
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term
10:50am, Wednesday, 23'rd Apr 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs
02:44am, Wednesday, 23'rd Apr 2025
The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European pharmaceutical giants said in a letter published in the Financial Times on
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
Novartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?
02:40pm, Monday, 21'st Apr 2025
NVS' first-quarter performance has likely benefited from strong growth in Kisqali, Kesimpta, Pluvicto, Leqvio, Scemblix and Fabhalta.
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio
12:50pm, Friday, 18'th Apr 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novartis (NVS) have what it takes?
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
08:56am, Thursday, 17'th Apr 2025
Equities are down this year because of Donald Trump's trade policies. The 47th U.S. president decided to impose steep tariffs on imported goods from most countries, although he has since significantly
Trump Says Pharmaceutical Tariffs Coming in Near Future
02:03pm, Monday, 14'th Apr 2025
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with repo
Sign In
Buy NVS